- Pfizer: If vaccine-escape variant emerges, expects to develop, produce new vaccine in about 100 days
Market news
26 November 2021
Pfizer: If vaccine-escape variant emerges, expects to develop, produce new vaccine in about 100 days
According to vaccine-maker Pfizer, in case there was a "vaccine-escape" variant, the company expects to be able to develop and produce a new tailor-made vaccine against that variant within about 100 days.
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page